Useful resources |
Physostigmine for dementia due to Alzheimer's disease (Cochrane Review) ABSTRACT Background: The main pharmacological approach for the treatment of Alzheimer's disease (AD) has been based on the use of agents potentiating cholinergic transmission, particularly by inhibiting acetylcholinesterase (AChE), the enzyme that destroys acetylcholine . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |